image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 11.745
0.902 %
$ 3.33 B
Market Cap
130.5
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one SHC stock under the worst case scenario is HIDDEN Compared to the current market price of 11.7 USD, Sotera Health Company is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one SHC stock under the base case scenario is HIDDEN Compared to the current market price of 11.7 USD, Sotera Health Company is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one SHC stock under the best case scenario is HIDDEN Compared to the current market price of 11.7 USD, Sotera Health Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SHC

image
$14.0$14.0$13.5$13.5$13.0$13.0$12.5$12.5$12.0$12.0$11.5$11.5$11.0$11.0$10.5$10.5$10.0$10.0$9.5$9.520252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25
FINANCIALS
1.1 B REVENUE
4.88%
298 M OPERATING INCOME
7.57%
44.4 M NET INCOME
-13.58%
224 M OPERATING CASH FLOW
251.74%
-179 M INVESTING CASH FLOW
16.71%
-50.6 M FINANCING CASH FLOW
-19.01%
255 M REVENUE
-12.29%
57 M OPERATING INCOME
-34.54%
-13.3 M NET INCOME
-107.66%
55.5 M OPERATING CASH FLOW
-0.35%
-19.9 M INVESTING CASH FLOW
69.82%
-8.09 M FINANCING CASH FLOW
-23.50%
Balance Sheet Sotera Health Company
image
Current Assets 526 M
Cash & Short-Term Investments 277 M
Receivables 166 M
Other Current Assets 83 M
Non-Current Assets 2.55 B
Long-Term Investments 0
PP&E 1.06 B
Other Non-Current Assets 1.48 B
9.03 %5.40 %34.65 %48.22 %Total Assets$3.1b
Current Liabilities 191 M
Accounts Payable 55.1 M
Short-Term Debt 22.8 M
Other Current Liabilities 113 M
Non-Current Liabilities 2.48 B
Long-Term Debt 2.33 B
Other Non-Current Liabilities 148 M
4.24 %87.29 %5.55 %Total Liabilities$2.7b
EFFICIENCY
Earnings Waterfall Sotera Health Company
image
Revenue 1.1 B
Cost Of Revenue 498 M
Gross Profit 602 M
Operating Expenses 305 M
Operating Income 298 M
Other Expenses 253 M
Net Income 44.4 M
1b1b1b1b800m800m600m600m400m400m200m200m001b(498m)602m(305m)298m(253m)44mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
54.73% GROSS MARGIN
54.73%
27.05% OPERATING MARGIN
27.05%
4.03% NET MARGIN
4.03%
10.96% ROE
10.96%
1.45% ROA
1.45%
4.00% ROIC
4.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Sotera Health Company
image
200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)(400m)(400m)20192019202020202021202120222022202320232024202420252025
Net Income 44.4 M
Depreciation & Amortization 164 M
Capital Expenditures -179 M
Stock-Based Compensation 36.8 M
Change in Working Capital -42.6 M
Others -20.9 M
Free Cash Flow 45.1 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Sotera Health Company
image
Wall Street analysts predict an average 1-year price target for SHC of $16.8 , with forecasts ranging from a low of $15 to a high of $18 .
SHC Lowest Price Target Wall Street Target
15 USD 27.71%
SHC Average Price Target Wall Street Target
16.8 USD 42.61%
SHC Highest Price Target Wall Street Target
18 USD 53.26%
Price
Max Price Target
Min Price Target
Average Price Target
18181717161615151414131312121111101099Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Sotera Health Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
376 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call. seekingalpha.com - 2 months ago
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago. zacks.com - 2 months ago
Sotera Health Reports First-Quarter 2025 Results CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025. globenewswire.com - 2 months ago
Sotera Health Announces First-Quarter 2025 Earnings Release Date CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights. globenewswire.com - 2 months ago
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock? Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately. zacks.com - 2 months ago
Sotera Health Has A Great Deleveraging Path Ahead Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging. seekingalpha.com - 2 months ago
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application globenewswire.com - 4 months ago
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call. seekingalpha.com - 4 months ago
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 4 months ago
Sotera Health Company (SHC) Meets Q4 Earnings Estimates Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago. zacks.com - 4 months ago
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2024 and its initial 2025 outlook. globenewswire.com - 4 months ago
8. Profile Summary

Sotera Health Company SHC

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 3.33 B
Dividend Yield 0.00%
Description Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Contact 9100 South Hills Boulevard, Broadview Heights, OH, 44147 https://soterahealth.com
IPO Date Nov. 20, 2020
Employees 3000
Officers Mr. Jonathan M. Lyons Senior Vice President & Chief Financial Officer Mr. Joseph A. Shrawder President of Nelson Labs Mr. Robert G. Hauzie Chief Information Officer Ms. Kristin A. Gibbs Chief Marketing Officer Ms. Sally R. Turner Chief Human Resources Officer Ms. Danielle J. Menture Senior Vice President of Global Environmental, Health & Safety and Sustainability Mr. Michael B. Petras Jr. Chairman & Chief Executive Officer Mr. Alexander Dimitrief J.D. Senior Vice President, General Counsel & Secretary Mr. Michael P. Rutz President of Sterigenics Mr. William O. Lehmann Jr., J.D., M.B.A. Senior Vice President of Strategy & Corporate Development